Our previous analysis of the signal transduction pathway used by the c-kit-encoded receptor for the stem cell factor (SCF) indicated efficient coupling to the type I phosphatidylinositoi 3' kinase (PI3K). In aid attempt to localize the receptor's site of interaction with PI3K, we separately deleted either the noncatalytic 68-amino-acM-long interkinase domain or the carboxyl-terminal portion distal to the catalytic sequences. Loss of ligand-induced association of P13K with the former deletion mutant and retention of the P13K association by the carboxyl-terminally deleted receptor implied interactions of P13K with the kinase insert. This was further supported by partial inhibition of the association by an anti-peptide antibody directed against the kinase insert and lack of effect of an antibody directed to the carboxyl tail of the SCF receptor. A bacterially expressed kinase insert domain was used as a fusion protein to directly test its presumed function as a i13K association site. This protein bound P13K from cell lysate as demonstrated by PI3K activity and by an associated phosphoprotein of 85 kDa. The association was dependent on phosphorylation of the tyrosine residues on the expressed kinase insert. On the basis of these observations, we conclude that the kinase insert domain of the SCF receptor selectively interacts with the p85 regulatory subunit of P13K and that this association requires phosphorylation of tyrosine residues in the kinase insert region, with apparently no involvement of the bulk cytoplasmic structure or tyrosine kinase function of the receptor.
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The mechanism by which extracellular soluble polypeptides transmit mitogenic, morphogenic, and differentiation signals into the cell interior has been the subject of intensive research in the last few years. Ohe of the best characterized signaling pathways involves a family of surface receptors with intrinsic tyrosine activity (1) . The c-kit protooncogene encodes such a receptor that shares structural homology with the receptors for the platelet-derived growth factor (PDGF) and the colonystimulating factor 1 (CSF-1). Originally identified by its relationships to a viral oncogene product (2) , this receptor carries a bisected tyrosine kinase domain that is interrupted by a 76-amino acid hydrophilic insert (3) . Even before the identity of its ligand was known, allelic relationships between the mouse c-kit gene (Kit) and the murine W locus indicated the involvement of the gene product in migration and proliferation of melanoblasts, erythroblasts, and germ cells (4, 5) .
Indeed, cloning of the mouse steel locus (SO, which encodes stem cell factor (SCF, called also the ligand for the Kit- encoded receptor and mast cell growth factor; refs. [6] [7] [8] and precise localization of various W mutations to the Kit coding sequences (9) (10) (11) directly supported the pleiotropic physiological role of this receptor.
By using a chimeric Kit-encoded receptor, we found that ligand stimulation activates a transforming potential of the tyrosine kinase (12) . Further analysis revealed that the activated Kit kinase is coupled to a unique combination of presumed second messenger-producing proteins, including phospholipase Cy, Rafl protein kinase, and phosphatidylinositol 3' kinase (PI3K), but it is nevertheless uncoupled to phosphatidylinositol turnover (13) . Of the identified substrates of Kit, PI3K was found to be the most efficiently associated with the receptor, in analogy to observations made with the platelet-derived growth factor (PDGF) receptor (14) (15) (16) (17) , the CSF-1 receptor (18) (19) (20) , and the receptor for the epidermal growth factor (EGF; ref. 21) . Although the specific role of P13K in mediating cell proliferation is not yet understood, this activity, which phosphorylates the 3' position of the inositoi ring (22) and associates with a number of growth factor receptors and transforming proteins, is believed to play a critidal role in signal transduction (23) . Purified P13K is a heterodimeric complex that contains p85 and p110 proteins (24) . DNA encoding the p85 subunit, which carries no nucleotide binding site, has been recently cloned and found to contain two src homology (SH2) domains (25) (26) (27) . The latter are thought to function as adaptor motifs that link tyrosine kinases to their substrates (28) .
In this study, we addressed the molecular interaction between the activated Kit-encoded receptor and P13K. By using deletion mutants of the receptor, antibodies to synthetic peptides, and a recombinant bacterial protein, we localized the site of interaction to the kinase insert (KI) domain of Kit. Apparently a specific tyrosine phosphorylation site and adjacent sequences, but not kinase activity and other gross structural determinants, are sufficient for reconstitution of the interaction in vitro.
MATERIALS AND METHODS
Cell Culture. Chinese hamster ovary (CHO) cells were trarisfected and selected for overexpression of the human c-kit cDNA as described (3) . The resulting cell line, denoted T18, was cultured in a modified Eagle's medium supplemented with 10% (vol/vol) calf serum. For expression of mutant receptors we used NIH 3T3 fibroblasts that were cultured in Dulbecco's-modified Eagle's medium supplemented with 10% calf serum.
Antibodies and Western Blotting. Antibodies to phosphotyrosine [Tyr(P)] were raised in rabbits as described (29) .
Antibodies to the extracellular domain of the Kit-encoded tyrosine kinase receptor that binds SCF as ligand (Kit/SCF receptor) were raised in rabbits injected with a recombinant extracellular domain of the human Kit/SCF-receptor (XR antiserum) and will be described elsewhere (the human gene is called KIT). Western blotting and detection with a chemiluminescence-based system (ECL, from Amersham) was performed as described (29 (30) downstream of the glutathione transferase coding sequence. Expression of the fusion protein (designated KI-GEX) was induced by the addition of 1 mM isopropyl 3-D-thiogalactopyranoside, and the protein was purified by affinity chromatography over a glutathione-agarose column essentially as described (30 In Vitro PI3K Association Assay. The Kit receptor was immunoprecipitated from serum-starved cells and then subjected to autophosphorylation. Washed immunoprecipitates were incubated for 90 min at 4°C with cell lysates that were prepared from NIH 3T3 cells and were washed again before PI3K activity was determined. Alternatively, they underwent a second phosphorylation reaction with [y-32P]ATP (see Fig.  3B ), and bound proteins were dissociated (31) and either reimmunoprecipitated with antibodies to phosphotyrosine [Tyr(P)] or incubated with KI (see Fig. 4B ).
RESULTS SCF Stimulates the Association of PI3K with Kit/SCF Receptor. Our previous study on signal transduction by Kit was performed with a chimeric receptor and a heterologous ligand (12, 13) . The availability of recombinant human SCF (6) enabled direct studies of the c-kit-encoded receptor, which we overexpressed in Chinese hamster ovary cells (T18 cells). Short incubation of SCF (50 ng/ml) with these cells resulted in association of P13K activity with the phosphorylated-tyrosine-containing receptor. This was indicated by the presence of PI3K activity in immunoprecipitates obtained with two antibodies to the Kit/SCF-receptor or antibodies to Tyr(P) (Fig. 1A) . Time-course analysis revealed rapid association of P13K with the receptor that peaked in 10 min and then gradually decreased (Fig. 1B) . Parallel analysis of the state of phosphorylation of the receptor tyrosine residues (Fig. 1B) showed continuous elevation of autophosphorylation that reached a plateau in 25 min and was followed by a limited decrease in Tyr(P) content (data not shown). These kinetics suggest that association with PI3K involves rapid but limited phosphorylation of the receptor tyrosine residues.
Carboxyl-Terminally Truncated Kit, but Not the AKI Mutant, Retains Interaction with P13K. To localize the receptor's domain that interacts with P13K activity, we attempted to delete noncatalytic regions of the cytoplasmic portion of Kit without affecting the integrity of the tyrosine kinase function. Site-directed mutagenesis enabled us to precisely delete the KI stretch of 68 amino acids (AKI mutant) and to construct separately a carboxyl-terminal deletion mutant (ACT) that practically contains no protein sequence distal to the tyrosine kinase (for details of the DNA construction, see Materials and Methods). When the modified cDNA molecules were stably expressed in cultured cells, they were found to retain ligand binding and tyrosine phosphorylation in response to SCF. However, the AKI mutant displayed partial reduction in autophosphorylation in vitro (data not shown). Fig. 2 incubation with freshly prepared cell extract. Later the immunoprecipitates were washed again and assayed for retention of P13K activity. The intervening cold phosphorylation step was essential for association with P13K (Fig. 3A) . Stimulated T18 cells. GrowthHowever, when the antiserum directed to the KI peptide 22TC with 50 ng of SCF for 15 (Ab213) was coincubated with the cell extract, it inhibited Is of time indicated in minutes retention of P13K activity by the phosphorylated receptor vere prepared and subjected to (Fig. 3A) . On the other hand, rabbit antiserum that was wing antibodies in A: rabbit directed against the most carboxyl-terminal 15 amino acids of irboxyl terminus of Kit (lanes Kit/SCF-receptor (Ab212) did not affect the interaction with rigin; PIP,phosphatidylinositol P13K (Fig. 3A) . This result correlates with the results obinositol bisphosphate. Antibodtained with the mutant receptors (Fig. 2) . In parallel exper-9 Lower) were used for immuiments we tried to inhibit the association by either Tyr(P) or )precipitates were assayed for phosphoserine. Both amino acids at 10 mM were ineffective icts PIP and PIP2 separated by (data not shown). This implies that although phosphorylation own in B. For B Upper, the of tyrosine is essential for the binding of P13K with the o gel electrophoresis followed receptor, the association probably requires Tyr(P) and addito Kit (Ab212) and by chemilutional adjacent amino acids. It has been previously reported A conjugated to horseradish that a phosphoprotein of 85 kDa is correlated with P13K activity (14) . To test the capacity of our Ab213 to inhibit vity was associated with the association with the p85 phosphoprotein, we assayed its ceptor but not with the mupresence in the immunoprecipitates shown in Fig. 3A . The he tyrosine phosphorylation assay involved the addition of [y-32P]ATP to each immunomutant is shown in Fig. 2 complex followed by specific elution and reprecipitation of duced self-phosphorylation phosphorylated tyrosine-containing proteins by anti-Tyr(P) due to direct reduction in antibodies. The results obtained (Fig. 3B) the inhibitory capacity of antibody 213 with disappearance of the 85-kDa protein band. Taken together, these results implicate the peptide sequence that includes tyrosine residues 721 and 730 of the KI in the physical coupling of Kit/SCF receptor with P13K and a p85 phosphoprotein.
Bacterially Expressed KI Domain Interacts with P13K Only in Its Phosphorylated Form. Assuming that the interaction between P13K and the KI of Kit/SCF receptor involves only a short protein sequence with no direct involvement of the receptor's catalytic function, it should be possible to reconstitute the association reaction with only the KI domain ofthe receptor. To test this prediction, we cloned the corresponding cDNA fragment of kit that encodes the 68 amino acids of the KI and fused it in-frame into the pGEX bacterial expression vector. The latter enabled expression ofthe KI sequence as a fusion protein with glutathione S-transferase (30) . The fusion protein was induced by the addition of isopropyl 3-D-thiogalactopyranoside to the medium of transformed bacteria, and was affinity-purified on immobilized glutathione. To determine the effect of phosphorylation of tyrosine residues of the bacterially expressed KI, we also subjected it to phosphorylation by a detergent-solubilized and immunoprecipitated tyrosine kinase of the EGF receptor. Fig. 4A depicts the results of Western blot analysis of the recombinant protein either phosphorylated or unphosphorylated. As shown, both antibodies to Tyr(P) and anti-peptide antiserum (Ab213) recognized the phosphorylated bacterially expressed fusion protein (36 kDa) (Fig. 4A) .
Using the recombinant KI peptide in an immobilized form, we assayed its ability to interact with the 85-kDa protein.
Detergent-solubilized NIH 3T3 cell extract was incubated with immunoprecipitates of the phosphorylated Kit-encoded receptor. The associated proteins underwent phosphorylation in the presence of [_-32P]ATP and were eluted and incubated with immobilized phosphorylated or unphosphorylated recombinant KI. The 85-kDa phosphoprotein was associated with the phosphorylated KI but not with unphosphorylated KI (Fig. 4B) . To test the association of PI3K activity with the KI, either recombinant KI (Fig. SA) or wild-type and AKI mutant receptors (Fig.  5B) were subjected to in vitro phosphorylation. Solubilized NIH 3T3 cell extract was then incubated with the immobilized phosphorylated proteins, and the associated PI3K activity in the precipitate was determined. Note that the recombinant KI protein was immobilized by two methods: either with an antibody or by a glutathione-agarose affinity matrix. Only phosphorylated recombinant KI and the wild-type receptor retained the capacity to associate with P13K activity (Fig. 5) . Nonphosphorylated KI or full receptor showed no activity. Similarly, the control GEX protein and the AKI mutant were also devoid of any associated PI3K activity, even when subjected to phosphorylation. to residues 719-735 (Ab213) further defines the sequence around tyrosine residues 721 and 730 as the site of interaction and suggests its function as an autophosphorylation site. Importantly, despite its inhibitory capacity, the Ab213-bound receptor or the KI could still capture P13K in an active form. Possibly this reflects the polyclonal nature of the antiserum and the different methods and antibody concentrations used to detect inhibitory (Fig. 3 ) versus immunoprecipitating potentials (Fig. 5) .
DISCUSSION
The molecular definition of the KI domain as the P13K effector site is consistent with the recent report of Bernstein and his collaborators (34) , who found that a 307-amino-acidlong portion of Kit, including the kinase insert domain, retained the ability to associate with PI3K. Moreover, both the PDGF receptor (15) and the CSF-1 receptor (19) interact with P13K through their respective KI domains. In fact, a phosphorylated peptide corresponding to the sequence around tyrosine-719 of the PDGF receptor blocked the association with P13K (35) . Similarly, an antiserum directed to residues 701-721 of the CSF-1 receptor (including the phosphorylation site at tyrosine-708) blocked the association of P13K with the CSF-1 receptor (36) . Both tyrosine residues 719 and 708 of the PDGF receptor and the CSF-1 receptor, respectively, are known to be autophosphorylation sites (16, 37, 38) . It is not yet known if tyrosine residues 721 and 730 of the Kit/SCF receptor are phosphorylated in vivo, but our present results predict that one or both residues function as sites of autophosphorylation. Although tyrosine phosphorylation per se was found to be essential for association with P13K, we could not inhibit the association of the receptor with P13K with Tyr(P) alone (results not shown). This suggests that the protein sequences flanking the phosphorylation site also participate in the recognition. Whatever the specificity is, our data clearly exclude a direct role for the catalytic function of the Kit/SCF receptor in mediating coupling to PI3K, since once phosphorylated on tyrosine residues, the isolated KI domain could associate with P13K with no involvement of the tyrosine kinase activity. This appears to be the case also for the PDGF (17) and the CSF-1 (36) receptors.
Apparently the Kit/SCF receptor carries more than one effector domain, as suggested by functional association also with phospholipase C. and Rafl (13) . This is in analogy with the PDGF receptor, which contains different sites of association with cytoplasmic substrates (39) . We currently try to identify these other sites and determine their involvements in mediating the mitogenic signal. Our preliminary results indicate that the KI deletion mutant of Kit retained interaction with the Rafl protein kinase, suggesting that this mutant may enable dissociation between direct substrates and the proliferative cellular response.
